Cell DeathAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantApoptosisCause of DeathAntineoplastic AgentsCombined Modality TherapyCisplatinTreatment OutcomeDoxorubicinCyclophosphamideDrug Administration ScheduleTime FactorsCell SurvivalCaspasesEtoposideDeathBreast NeoplasmsSurvival AnalysisNeoadjuvant TherapyDose-Response Relationship, DrugDisease-Free SurvivalSurvival RatePrognosisLung NeoplasmsCell Line, TumorNeoplasmsNeoplasm StagingNecrosisMethotrexatePaclitaxelCaspase 3Proto-Oncogene Proteins c-bcl-2Drug Resistance, NeoplasmCarboplatinFollow-Up StudiesVinblastineNeoplasm Recurrence, LocalDNA FragmentationSignal TransductionTaxoidsInduction ChemotherapyMitochondriaAntineoplastic Agents, PhytogenicAntimetabolites, AntineoplasticAutophagyCells, CulturedIfosfamideBleomycinDeoxycytidineAntineoplastic Agents, AlkylatingProspective StudiesIn Situ Nick-End LabelingOrganoplatinum CompoundsCytarabinebcl-2-Associated X ProteinAdministration, OralRadiotherapy DosageCaspase InhibitorsReactive Oxygen SpeciesAdenocarcinomaOvarian NeoplasmsCarcinoma, Non-Small-Cell LungInfusions, IntravenousAnthracyclinesNeoplasm MetastasisDeath, Sudden, CardiacSalvage TherapyTumor Cells, CulturedVomitingAntibiotics, AntineoplasticNeutropeniaAntigens, CD95Cell LineTransplantation, AutologousClinical Trials as TopicNauseaChemotherapy, Cancer, Regional PerfusionRadiotherapyLymphoma, Non-HodgkinImmunohistochemistryBrain NeoplasmsKaplan-Meier EstimateColorectal NeoplasmsTumor Suppressor Protein p53CamptothecinEnzyme ActivationHodgkin DiseaseTesticular NeoplasmsBrain DeathApoptosis Regulatory ProteinsAntibodies, MonoclonalDrug SynergismRecurrenceCell ProliferationDose-Response Relationship, RadiationRadiotherapy, AdjuvantDacarbazineLiver NeoplasmsRats, Sprague-Dawley